IGFBP3 and diabetes mellitus: Since short hairpin RNA (shRNA) emerges as a technology to silence gene expression by inhibiting mRNA translation and/or inducing its degradation (8), therefore, in this study we employed shRNA technology to investigate whether intracavernosal injection of shRNA for IGFBP-3 can ameliorate diabetes-related ED.